Emory University’s Cocrystal Pharma COCP Stock Holding History

Emory University’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12,743	Closed	-$232K	–	5
2020 Q2	$232K	Hold	12,743	–	–	41.65%	2
2020 Q1	$109K	Hold	12,743	–	–	28.61%	2
2019 Q4	$76K	Hold	12,743	–	–	4.74%	3
2019 Q3	$312K	Hold	12,743	–	–	0.62%	17
2019 Q2	$359K	Hold	12,743	–	–	0.25%	44
2019 Q1	$417K	Hold	12,743	–	–	0.29%	44
2018 Q4	$550K	Hold	12,743	–	–	0.43%	44
2018 Q3	$382K	Hold	12,743	–	–	0.25%	44
2018 Q2	$560K	Hold	12,743	–	–	0.37%	43
2018 Q1	$910K	Buy	+12,743	New	+$795K	0.65%	44

Other funds holding COCP

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Emory University's COCP Position: Q3 2020 in Review

Emory University sold out of Cocrystal Pharma (COCP) in Q3 2020, closing a stake of 12,743 shares — an estimated $232K sold.

Emory University first reported a position in COCP in Q1 2018 and held it in 10 quarters. The position peaked at $910K in Q1 2018. 25 funds tracked by Wall St. Rank hold COCP as of Q3 2020.

Emory University reported no remaining Cocrystal Pharma position as of Q3 2020 after selling out during the quarter.
Emory University sold 12,743 Cocrystal Pharma shares in Q3 2020, an estimated $232K.
Emory University first reported a position in Cocrystal Pharma in Q1 2018 and held it in 10 quarters.
Emory University's Cocrystal Pharma position peaked at $910K in Q1 2018.
25 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2020.

Based on Emory University's 13F filing for Q3 2020, filed 16 Nov 2020.